CTRI/2016/10/007381Not yet recruitingPhase 4
â??Therapeutic Drug Monitoring of Phenytoin,Carbamazepine and Sodium Valproate in Patientswith Epilepsy by High Performance LiquidChromatography (HPLC) in A Tertiary Health CareTeaching Hospital: A Prospective ObservationalStudyâ??
Department of Pharmacology Government Medical College Bhavnagar0 sites105 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 4
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 105
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
Inclusion Criteria
- •Patients of any age and both gender who are willing to give written inform consent.
- •In case of patients less than 18 years of age guardian must be there to provide written inform consent.
- •Patients on Anti-Epileptic treatment with Phenytoin, Carbamazepine or Sodium valproate and in combination therapy with any of these or other Anti-Epileptic drugs for six months or more.
Exclusion Criteria
- •Patients on Anti-Epileptic Drugs for less than six months.
- •Patients on these drugs for indication other than Epilepsy.
- •Patients with history of hepatitis-B OR hepatitis-C
- •Patient who do not give consent.
Investigators
Similar Trials
Not yet recruiting
Phase 1
Therapeutic drug monitoring of mycophenolic acid and validation of limited sampling strategies for the estimation area under the mycophenolic acid concentration-time curve in Thai pediatric renal transplant recipients at Siriraj hospitalevel of MPA in pediatric kidney transplantedInfectionTCTR20170206004Faculty of Medicine Siriraj Hospital25
Not yet recruiting
Not Applicable
Pharmacokinetics and Therapeutic Drug Monitoring of Intravenous Sulbactam in PediatricsPK parameters of sulbactam in pediatric patients with proven or suspected multidrug resistance A. baumannii infection receiving intravenous sulbactamSulbactam, TDM, pharmacokinetics, A. baumannnii, pediatricsTCTR20221114001Ratchadapisek Sompoch Research Fund62
Recruiting
Not Applicable
Comfirmation of therapeutic drug monitoring for pulmonary hypertensiopulmonary hypertensionJPRN-UMIN000022593Department of Clinical Pharmacology and Therapeutics, Hamamatsu University School of Medicine50
Active, not recruiting
Not Applicable
Survey of Cabozantinib Used To Treat People With Renal Cell CarcinomaRenal cell carcinomaJPRN-jRCT2031210003Contact for Clinical Trial Information388
Recruiting
Not Applicable
Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitorsmalignancies10027655cancerNL-OMON53128Antoni van Leeuwenhoek Ziekenhuis1,500